25.10.2018
... the Company’s key development assumptions. Wolfgang Bender, Chief Medical Officer of Valneva ...
25.10.2018
... des Unternehmens, so das Unternehmen. Wolfgang Bender, Chief Medical Officer von Valneva ...
16.10.2018
... in the VLA1553 clinical development. Wolfgang Bender, MD, PhD, Chief Medical Officer ...
16.10.2018
... Impfstoff ausgelösten Virämie geschützt sind. Wolfgang Bender, Chief Medical Officer von Valneva ...
02.07.2018
... ), David Lawrence (Chief Financial Officer), Wolfgang Bender (Chief Medical Officer) und Frederic ...
22.05.2018
... ) Frédéric Jacotot (Board Member) Wolfgang Bender (Board Member) David Lawrence (CFO ...
06.04.2018
... ) Frédéric Jacotot (Board Member) Wolfgang Bender (Board Member) David Lawrence (CFO ...
04.04.2018
... Frédéric Jacotot (Board Member) Wolfgang Bender (Board Member) David Lawrence ( ... im Umsatzranking YTD im ATX. Wolfgang Anzengruber (CEO) Peter Kollmann ...
22.03.2018
... ) Frédéric Jacotot (Board Member) Wolfgang Bender (Board Member) David Lawrence (CFO ...
19.03.2018
... für die verschiedenen OspA-Serotypen. Wolfgang Bender, MD, PhD, Chief Medical ... ric Jacotot (Board Member) Wolfgang Bender (Board Member) David Lawrence ...